873 related articles for article (PubMed ID: 14691250)
21. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
[TBL] [Abstract][Full Text] [Related]
22. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation.
Gewurz BE; Mar JC; Padi M; Zhao B; Shinners NP; Takasaki K; Bedoya E; Zou JY; Cahir-McFarland E; Quackenbush J; Kieff E
J Virol; 2011 Jul; 85(13):6764-73. PubMed ID: 21543491
[TBL] [Abstract][Full Text] [Related]
23. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
Fries KL; Miller WE; Raab-Traub N
Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
[TBL] [Abstract][Full Text] [Related]
24. Nuclear factor-κB2 represses Sp1-mediated transcription at the CD99 promoter.
Lee EK; Chae JH; Kang MS
Mol Cells; 2011 Dec; 32(6):555-60. PubMed ID: 22083306
[TBL] [Abstract][Full Text] [Related]
25. Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation.
Razani B; Zarnegar B; Ytterberg AJ; Shiba T; Dempsey PW; Ware CF; Loo JA; Cheng G
Sci Signal; 2010 May; 3(123):ra41. PubMed ID: 20501937
[TBL] [Abstract][Full Text] [Related]
26. IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program.
Li X; Massa PE; Hanidu A; Peet GW; Aro P; Savitt A; Mische S; Li J; Marcu KB
J Biol Chem; 2002 Nov; 277(47):45129-40. PubMed ID: 12221085
[TBL] [Abstract][Full Text] [Related]
27. TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation.
Greenfeld H; Takasaki K; Walsh MJ; Ersing I; Bernhardt K; Ma Y; Fu B; Ashbaugh CW; Cabo J; Mollo SB; Zhou H; Li S; Gewurz BE
PLoS Pathog; 2015 May; 11(5):e1004890. PubMed ID: 25996949
[TBL] [Abstract][Full Text] [Related]
28. Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation.
Kim JE; Kim SY; Lim SY; Kieff E; Song YJ
Mol Cell Biol; 2014 Feb; 34(3):325-34. PubMed ID: 24248603
[TBL] [Abstract][Full Text] [Related]
29. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
Senftleben U; Cao Y; Xiao G; Greten FR; Krähn G; Bonizzi G; Chen Y; Hu Y; Fong A; Sun SC; Karin M
Science; 2001 Aug; 293(5534):1495-9. PubMed ID: 11520989
[TBL] [Abstract][Full Text] [Related]
30. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF.
Yilmaz ZB; Weih DS; Sivakumar V; Weih F
EMBO J; 2003 Jan; 22(1):121-30. PubMed ID: 12505990
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
Kilger E; Kieser A; Baumann M; Hammerschmidt W
EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
[TBL] [Abstract][Full Text] [Related]
32. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
Yang CH; Murti A; Pfeffer LM
J Biol Chem; 2005 Sep; 280(36):31530-6. PubMed ID: 16009713
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
[TBL] [Abstract][Full Text] [Related]
34. The Latent Membrane Protein 1 (LMP1).
Kieser A; Sterz KR
Curr Top Microbiol Immunol; 2015; 391():119-49. PubMed ID: 26428373
[TBL] [Abstract][Full Text] [Related]
35. TRAF1 is a critical regulator of JNK signaling by the TRAF-binding domain of the Epstein-Barr virus-encoded latent infection membrane protein 1 but not CD40.
Eliopoulos AG; Waites ER; Blake SM; Davies C; Murray P; Young LS
J Virol; 2003 Jan; 77(2):1316-28. PubMed ID: 12502848
[TBL] [Abstract][Full Text] [Related]
36. B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.
Bhattacharyya S; Borthakur A; Tyagi S; Gill R; Chen ML; Dudeja PK; Tobacman JK
J Biol Chem; 2010 Jan; 285(1):522-30. PubMed ID: 19897484
[TBL] [Abstract][Full Text] [Related]
37. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
Busch LK; Bishop GA
J Immunol; 2001 Nov; 167(10):5805-13. PubMed ID: 11698454
[TBL] [Abstract][Full Text] [Related]
38. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.
Saito N; Courtois G; Chiba A; Yamamoto N; Nitta T; Hironaka N; Rowe M; Yamamoto N; Yamaoka S
J Biol Chem; 2003 Nov; 278(47):46565-75. PubMed ID: 12968033
[TBL] [Abstract][Full Text] [Related]
39. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
40. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
